CUSIP: 75082Q105
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,165,995
-
Share change
-
+6,804,071
-
Total reported value
-
$169,301,834
-
Put/Call ratio
-
9.1%
-
Price per share
-
$8.00
-
Number of holders
-
45
-
Value change
-
+$55,716,575
-
Number of buys
-
29
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 75082Q105?
CUSIP 75082Q105 identifies RAIN - RAIN ONCOLOGY INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 75082Q105:
Institutional Holders of RAIN ONCOLOGY INC - COM (RAIN) as of Q4 2022
As of 31 Dec 2022,
RAIN ONCOLOGY INC - COM (RAIN) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,165,995 shares.
The largest 10 holders included
BVF INC/IL, Cormorant Asset Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PERCEPTIVE ADVISORS LLC, Samsara BioCapital, LLC, Boxer Capital, LLC, JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., GMT CAPITAL CORP, and VANGUARD GROUP INC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.